Aura Biosciences, Inc. (AURA) vs ArriVent BioPharma, Inc. (AVBP)

A side-by-side comparison of Aura Biosciences, Inc. and ArriVent BioPharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Aura Biosciences, Inc. logo
AURA
Aura Biosciences, Inc.
$635M
$6.14HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
ArriVent BioPharma, Inc. logo
AVBP
ArriVent BioPharma, Inc.
$706M
$15.15HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

Total return — AURA vs AVBP

growth of $100 · dividends reinvested · last 3y
AURA -18.1% (-6.4%/yr)AVBP +42.3% (+12.5%/yr)AVBP compounded faster over this window
100150Start $10020252026$82$142
AURA AVBP

AURA vs AVBP: by the numbers

  • •AVBP is the larger company ($706M vs $635M market cap).

Metrics side by side

Valuation

MetricAURAAVBP
P/B ratio2.021.92

Profitability

MetricAURAAVBP
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-41.56%-44.63%
ROIC-42.02%-47.96%

Go deeper

Full AURA analysisFull AVBP analysisInteractive comparison tool

Dig into the metrics

Aura Biosciences ROEArriVent BioPharma ROEAura Biosciences operating marginArriVent BioPharma operating marginAura Biosciences revenue growthArriVent BioPharma revenue growthAura Biosciences free cash flowArriVent BioPharma free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.